withdrawn after failing to show any survival benefit in the PROWESS-SHOCK trial. recommendation is to stop it immediately on any patients currently getting the therapy and not start it on any new ones.
http://www.fda.gov/Safety/MedWatch/...tyAlertsforHumanMedicalProducts/ucm277143.htm
http://www.fda.gov/Safety/MedWatch/...tyAlertsforHumanMedicalProducts/ucm277143.htm
